Clinical features in adults with acquired cutis laxa: a retrospective review
- PMID: 36849736
- PMCID: PMC10230959
- DOI: 10.1093/bjd/ljad043
Clinical features in adults with acquired cutis laxa: a retrospective review
Abstract
Acquired cutis laxa (ACL) is a very rare dermatological condition with numerous proposed aetiologies. Herein, we report on 10 adult patients with ACL, three of which were found to have genetic mutations suggesting a genetic predisposition for the development of ACL following exposure to an environmental insult. Four patients were presumed to develop ACL in association with medication exposure. Overall, if a case of potential ACL arises, providers should carefully review patient history and comorbidities, perform thorough systemic investigations based on symptomatology, and consider genetic analysis.
Conflict of interest statement
Conflicts of interest A.H.L. is the PI for a research grant from Pfizer exploring the role of the JAK/STAT pathway in connective tissue disease. M.S.M. is on the advisory board of Horizon.
References
-
- Kumar P, Savant SS, Das A. Generalized acquired cutis laxa type 1: a case report and brief review of literature. Dermatol Online J 2016; 22:13030/qt8rb7f7w1. - PubMed
-
- Tan JK, Lipworth AD, Nelson AA. et al. Part III: Cutaneous hypersensitivity during selective serotonin reuptake inhibitor therapy resulting in acquired cutis laxa. J Drugs Dermatol 2011; 10:215–16. - PubMed
-
- Vajdi T, Lee WW, Paravar T. Penicillamine-associated cutis laxa and miliaen plaque – case report and review of cutaneous changes associated with penicillamine. Dermatol Online J 2016; 22:13030/qt47p4d8zv. - PubMed
-
- Jachiet M, Harel S, Saussine A. et al. Cutis laxa associated with monoclonal gammopathy: 14 new cases and review of the literature. J Am Acad Dermatol 2018; 79:945–7. - PubMed